Skip to main content
TipRanks
Go Ultimate75% OFF

ADC Therapeutics (ADCT) Q3 2022 Earnings Report

441 Followers

ADCT Q3 2022 EPS Results

Actual EPS
-$0.65
Consensus EPS
-$0.35
Beat/Miss
Missed by -$0.30
One Year Ago EPS
-$0.93

ADCT Q3 2022 Revenue Results

Actual Revenue
$76.32M
Expected Revenue
$60.70M
Beat/Miss
Beat by +$15.62M
YoY Revenue Growth
+480.52%

Earnings Announcement Details

Quarter
Q3 2022
Date
11/08/2022
Time
Before Open
Conference Call
Tuesday, November 8, 2022
ADCT Upcoming Earnings

ADC Therapeutics's next earnings date is estimated for March 17, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

ADCT Q3 2022 Earnings Call
0:00 / 0:00

Q3 2022 Earnings Slide Deck

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

ADCT Earnings History

ADCT earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 17, 20272026 (Q4)-0.17--0.04――
Nov 09, 20262026 (Q3)-0.21-0.16-0.346.67% (+0.14)
Aug 13, 20262026 (Q2)-0.22-0.11-0.578.00% (+0.39)
May 04, 20262026 (Q1)-0.20-0.21-0.3641.67% (+0.15)
Mar 10, 20262025 (Q4)-0.27-0.04-0.2986.21% (+0.25)
Nov 10, 20252025 (Q3)-0.36-0.30-0.4228.57% (+0.12)
Aug 12, 20252025 (Q2)-0.49-0.50-0.38-31.58% (-0.12)
May 14, 20252025 (Q1)-0.40-0.36-0.5635.71% (+0.20)
Mar 27, 20252024 (Q4)-0.41-0.29-1.0371.84% (+0.74)
Nov 07, 20242024 (Q3)-0.40-0.42-0.5827.59% (+0.16)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed